BPC-157 (20mg)
High-strength (20 mg) BPC-157 vial for long cycles or higher doses with fewer vial changes. Ideal for researchers following intensive protocols.
Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16
Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.
⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer
Research monograph
See the full BPC-157 encyclopedia page with mechanism, evidence tier, related variants and research context.
How It Works
BPC-157 regulates nitric oxide pathways and the expression of growth factors for angiogenesis and collagen deposition. Animal models report accelerated healing of tendons, ligaments, and muscle injuries.
Quick Start
- Reconstitution: Add 4.0 mL bacteriostatic water → 5.0 mg/mL concentration.
- Typical daily range: 250–750 mcg once daily.
- Storage: Lyophilized: −20 °C; reconstituted: 2–8 °C.
Typical Approach (4 mL = 5.0 mg/mL)
Route: Subcutaneously | Frequency: Once daily
| Week | Dose | Units (per injection) |
|---|---|---|
| Weeks 1–2 | 250 mcg (0.25 mg) | 5 Units (0.05 mL) |
| Weeks 3–4 | 500 mcg (0.5 mg) | 10 Units (0.10 mL) |
| Weeks 5–12 | 750 mcg (0.75 mg) | 15 Units (0.15 mL) |
Studies report administration once daily subcutaneously. The 20 mg vial covers ~27–80 days depending on the dose.
Related compounds
Reconstitution Steps
- Draw 4.0 mL of bacteriostatic water.
- Slowly inject onto the side of the vial.
- Gently swirl until fully dissolved.
- Refrigerate at 2–8 °C; use within 28 days.
Protocol Overview
- Goal: Intensive tissue healing support.
- Schedule: Daily injections for 8–12 weeks.
Dosing Protocol
- Initiation: 250 mcg daily; increase every 2 weeks.
- Target: 500–750 mcg daily.
- Cycle Duration: 8–12 weeks.
- Break between cycles: A 2–4 week break after the cycle.
Washout & Cycle Restart
When can I restart?
A 2–4 week break after the cycle.
Minimum wait period: 4 weeks
Storage Instructions
- Lyophilized: −20 °C.
- Reconstituted: 2–8 °C, use within 28 days.
Important Notes
- The 20 mg vial reduces the frequency of vial changes.
- Use sterile technique for every dose withdrawal.
- Human clinical data remain limited.
Potential Benefits & Side Effects
Potential Benefits:
- Supports tissue repair (animal data).
- Anti-inflammatory properties.
- Fewer vial changes with the higher strength.
- More cost-effective per mg compared to smaller vials.
Potential Side Effects:
- Injection site reactions: redness, swelling, stinging (15–25%).
- Transient nausea (5–10%, mainly the first week).
- Dizziness (3–7%, rare).
- Human clinical data are very limited.
⚠️ Serious Warnings & Long-Term Risks
The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.
Theoretical concern: angiogenesis & oncogenesis
BPC-157 promotes angiogenesis (VEGF upregulation). May theoretically enhance blood supply to existing tumors. No clinical data in humans.
📄 J Physiol Pharmacol 2010References
- Journal of Pharmacological Sciences — BPC-157 and NO-system regulation
View Source - Pharmaceuticals (MDPI) — Multifunctionality of BPC-157
View Source - Current Pharmaceutical Design — BPC-157 stable gastric peptide
View Source
Recommended Supplements
Curcumin (Turmeric Extract)
Collagen Peptides
External Sources & Regulatory Status
Regulatory Approvals
Research-only — No regulatory approval (extensive preclinical research)
Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.
Continue Your Research
Explore tools and guides related to this protocol.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →